How is Gazyva different from Rituxan?

Gazyva (obinutuzumab) used to treat specific types of leukemia and lymphoma, but has some severe side effects. Calms down your immune system. Rituxan (Rituximab) is effective for treating multiple types of cancer and arthritis.

Is rituximab the same as GAZYVA?

Are Rituxan and Gazyva the Same Thing? Rituxan (rituximab) and Gazyva (obinutuzumab) are monoclonal antibodies used to treat different kinds of cancer. Rituxan used in combination with other cancer medicines to treat non-Hodgkin's lymphoma.

Is GAZYVA better than Rituxan?

Obinutuzumab was developed to potentiate activity and overcome resistance. Pre-clinical data suggests obinutuzumab is superior to rituximab at effecting B cell depletion; however recent phase III clinical trial results have been mixed.

Is GAZYVA immunotherapy or chemotherapy?

Gazyva™ is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Gazyva™ is classified as a "monoclonal antibody" (For more detail, see "How Gazyva™ Works" section below).

What's the difference between Rituxan and rituximab?

Rituxan is the trade name for rituximab. In some cases, health care professionals may use the trade name rituxan when referring to the generic drug name rituximab. Drug type: Rituximab is a monoclonal antibody. (For more detail, see "How this drug works" section below).

26 related questions found

What drug is similar to Rituxan?

Riabni, Ruxience, and Truxima are biosimilars to Rituxan (rituximab). A biosimilar is a biologic medication that's highly similar to the original biologic that was first approved by the FDA.

What diseases is Rituxan used for?

Rituximab injection is used alone or together with other medicines to treat a type of cancer called non-Hodgkin's lymphoma (NHL). It is also used in combination with other cancer medicines to treat mature B-cell non-Hodgkin's lymphoma (NHL) and mature B-cell acute leukemia (B-AL).

Is GAZYVA chemo?

GAZYVA® (obinutuzumab) is a prescription medicine used with the chemotherapy drug, chlorambucil, to treat chronic lymphocytic leukemia (CLL) in adults who have not had previous CLL treatment.

How often is GAZYVA given?

GAZYVA is given for a total of 6 cycles, or rounds of treatment. Each cycle will last 28 days. Treatment occurs only on certain days of each cycle and that is usually followed by several weeks of rest and recovery. This means that most people will complete their GAZYVA treatment in about 6 months.

Do you lose your hair with GAZYVA?

You could lose all your hair. This includes your eyelashes, eyebrows, underarm, leg and sometimes pubic hair. Your hair will usually grow back once treatment has finished but it is likely to be softer. It may grow back a different colour or be curlier than before.

How long is a Gazyva infusion?

Administer at 25 mg/hr over 4 hours. Do not increase the infusion rate. The Day 1 dose for GAZYVA is 100 mg in 100 mL.

What are side effects of Gazyva?

Common side effects of Gazyva include:

  • infusion reactions,
  • nausea,
  • vomiting,
  • diarrhea,
  • high blood pressure (hypertension),
  • flushing,
  • headache,
  • fever,

What is the difference between Obinutuzumab and rituximab?

Obinutuzumab is a type II antibody, unlike rituximab, which is a type I antibody. These classifications are based on the way the antibodies bind to CD20.

Is rituximab a monoclonal antibody?

Rituximab is a chimeric mouse/human monoclonal antibody (mAb) therapy with binding specificity to CD20.

Is chlorambucil a chemotherapy?

Chlorambucil is a chemotherapy drug and is also known by its brand name Leukeran. It is used mainly to treat: chronic lymphocytic leukaemia (CLL) Non-Hodgkin lymphoma.

Who makes Ibrutinib?

IMBRUVICA® is a once-daily, first-in-class Bruton's tyrosine kinase (BTK) inhibitor that is administered orally, and is jointly developed and commercialized by Janssen Biotech, Inc. and Pharmacyclics LLC, an AbbVie company.

What is the cost of GAZYVA?

Cost of Gazyva is $41,300 for one 6-month course of treatment. Additional information can be found at

How is GAZYVA administered?

Each dose of GAZYVA is 1000 mg, administered intravenously, with the exception of the first infusions in Cycle 1, which are administered on day 1 (100 mg) and day 2 (900 mg).

What is Obinutuzumab used for?

Descriptions. Obinutuzumab injection is used together with other medicines (eg, chlorambucil) to treat chronic lymphocytic leukemia (CLL). Obinutuzumab injection is also used together with bendamustine to treat follicular lymphoma after other medicines (eg, rituximab) did not work well.

Is rituximab chemotherapy?

RITUXAN is not chemotherapy. RITUXAN is a type of antibody therapy that can be used alone or with chemotherapy. They work in different ways to find and attack the cells where cancer starts. RITUXAN targets and attaches to the CD20 protein found on the surface of blood cells with cancer and some healthy blood cells.

Does GAZYVA cause low white blood cell count?

The most common side effects of GAZYVA in CLL were infusion-related reactions and low white blood cell counts.

Does GAZYVA cause low blood pressure?

You may be given medicines to take before each GAZYVA treatment. Symptoms of IRRs may include: fast heartbeat, tiredness, dizziness, headache, redness of the face, nausea, chills, fever, vomiting, diarrhea, rash, high blood pressure, low blood pressure, difficulty breathing, and chest discomfort.

Is Rituxan an immunotherapy?

Rituxan is a monoclonal antibody medication. It's also considered a type of immunotherapy, meaning it helps turn the immune system against cancer. It works by identifying and labeling certain white blood cells (B cells) for destruction by the body's immune system.

Does Rituxan lower immune system?

Rituxan can increase your risk of getting infections and can lower the ability of your immune system to fight infections. People with serious infections should not receive Rituxan. Heart Problems: Rituxan may cause chest pain, irregular heartbeats, and heart attack.

How do you know if Rituxan is working?

Rituximab works by lowering the number of these B-cells, to reduce inflammation, pain, swelling and joint damage. If rituximab works for you, you'll probably notice an improvement in your symptoms 8-16 weeks after you start treatment.

You Might Also Like